Abpro Bio Co., Ltd. announced that it has received KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.
November 25, 2020
Share
On November 26, 2020, Abpro Bio Co., Ltd. (KOSDAQ:A195990) closed the transaction. The company
Share
© S&P Capital IQ - 2020